Citation Impact
Citing Papers
Molecular Analysis of Commensal Host-Microbial Relationships in the Intestine
2001 StandoutScience
Genetic polymorphism of CYP2A6 gene and tobacco-induced lung cancer risk in male smokers.
2002
CYP2A6: genetics, structure, regulation, and function
2012
CYP2A6Polymorphisms and Risk for Tobacco-Related Cancers
2008
Nicotine Chemistry, Metabolism, Kinetics and Biomarkers
2009 Standout
Single-Dose Methoxsalen Effects on Human Cytochrome P-450 2A6 Activity
2000
Contrast Medium-Induced Acute Kidney Injury
2015 Standout
CNVs of human genes and their implication in pharmacogenetics
2008
In vivo analysis of efavirenz metabolism in individuals with impaired CYP2A6 function
2009
Nicotine metabolism: the impact of CYP2A6 on estimates of additive genetic influence
2005
CYP2A6: a human coumarin 7-hydroxylase
2000
Orphans in the Human Cytochrome P450 Superfamily: Approaches to Discovering Functions and Relevance in Pharmacology
2011
Polymorphism of human cytochrome P450 enzymes and its clinical impact
2009
Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants
2003
Slower Metabolism and Reduced Intake of Nicotine From Cigarette Smoking in Chinese-Americans
2002
Sex Differences in the Expression of Hepatic Drug Metabolizing Enzymes
2009
Artemisinin and CYP2A6 activity in healthy subjects
2007
Pharmacokinetics of nicotine in kidney failure
2000
Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer
2002
Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy
2006
Cytochrome P450 pharmacogenetics and cancer
2006
Microplastics in bivalves cultured for human consumption
2014 Standout
A Novel Duplication Type of CYP2A6 Gene in African-American Population
2007
Chronic kidney disease
2011 Standout
Contrast media for angiography: Physicochemical properties, pharmacokinetics and biocompatibility
1991
Functional Characterization of CYP2B6 Allelic Variants in Demethylation of Antimalarial Artemether
2011
Nitric oxide deficiency in chronic kidney disease
2007
Polymorphic NF-Y dependent regulation of human nicotine C-oxidase (CYP2A6)
2004
Metabolism and Disposition Kinetics of Nicotine
2005
Preventing Occupational Exposures to Antineoplastic Drugs in Health Care Settings
2006 Standout
Studies on Coumarins and Coumarin-Related Compounds to Determine their Therapeutic Role in the Treatment of Cancer
2004 Standout
Enhanced protein glutathiolation and oxidative stress in cigarette smokers
2003
Molecular Genetics of Nicotine Metabolism
2009
Inhibition of cytochrome P450 2A6 increases nicotine's oral bioavailability and decreases smoking
2000
Hepatic CYP2A6 levels and nicotine metabolism: impact of genetic, physiological, environmental, and epigenetic factors
2009
Human corneal stromal tissue concentration after consecutive doses of topically applied 3.3% vancomycin
2003
Consensus Guidelines for the Management of Postoperative Nausea and Vomiting
2013 Standout
The Importance of Race and Ethnic Background in Biomedical Research and Clinical Practice
2003 Standout
Three haplotypes associated with CYP2A6 phenotypes in Caucasians
2005
Oxidative stress and redox regulation of lung inflammation in COPD
2006 Standout
Genotoxicity of pesticides: a review of human biomonitoring studies
2003
Polymorphisms of CYP2A6 and its practical consequences
2001
Assessment of vinyl chloride-induced DNA damage in lymphocytes of plastic industry workers using a single-cell gel electrophoresis technique
1998
Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment
1999
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
2009 StandoutNature
A review of airborne polycyclic aromatic hydrocarbons (PAHs) and their human health effects
2013 Standout
Organization, structure and evolution of the CYP2 gene cluster on human chromosome 19
2001
Cytochrome P450 2A6 polymorphism in nasopharyngeal carcinoma
2005
Acetylcholinesterase Inhibitors: Pharmacology and Toxicology
2013 Standout
Biodegradation of the iodinated X-ray contrast media diatrizoate and iopromide
1999
Determinants of the rate of nicotine metabolism and effects on smoking behavior
2006
Population genetic structure of variable drug response
2001
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
Pharmacogenetics of the major polymorphic metabolizing enzymes
2003
Coffee and Health: A Review of Recent Human Research
2006 Standout
Herb-Drug Interactions
2005 Standout
Prevention of Postoperative Nausea and Vomiting with Granisetron and Dolasetron in Relation to CYP2D6 Genotype
2006
Evidence for Gradients of Human Genetic Diversity Within and Among Continents
2004 StandoutNobel
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Plasma Letrozole Concentrations in Postmenopausal Women With Breast Cancer Are Associated With CYP2A6 Genetic Variants, Body Mass Index, and Age
2011
CYP2A6 genotype and the metabolism and disposition kinetics of nicotine
2006
Neurobiology of addiction: a neurocircuitry analysis
2016 Standout
Arginine metabolism and nutrition in growth, health and disease
2008 Standout
Comprehensive evaluation of variability in nicotine metabolism and CYP2A6 polymorphic alleles in four ethnic populations
2006
Nicotine replacement therapy for smoking cessation
2012 Standout
The Enigmatic Epidemiology of Nasopharyngeal Carcinoma
2006 Standout
CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants
2002
Clinical practice guidelines for antimicrobial prophylaxis in surgery
2013 Standout
Review on Natural Coumarin Lead Compounds for Their Pharmacological Activity
2013 Standout
Genetic Structure of Human Populations
2002 StandoutScience
2003 Standout
Worldwide Variation in Human Drug-Metabolism Enzyme GenesCYP2B6andUGT2B7: Implications for HIV/AIDS Treatment
2012
NewCYP2A6Gene Deletion and Conversion Variants in a Population of Black African Descent
2010
Pesticide Exposure, Safety Issues, and Risk Assessment Indicators
2011 Standout
GLUTATHIONE TRANSFERASES
2004 Standout
Single and Coupled Electrochemical Processes and Reactors for the Abatement of Organic Water Pollutants: A Critical Review
2015 Standout
Pharmacogenetic testing among patients with mood and anxiety disorders is associated with decreased utilization and cost: A propensity-score matched study
2018 StandoutNobel
Drinking water contamination and treatment techniques
2016 Standout
Pharmaceuticals and personal care products in the environment: agents of subtle change?
1999 Standout
Removal of the X-ray Contrast Media Diatrizoate by Electrochemical Reduction and Oxidation
2013
The comet assay as a rapid test in biomonitoring occupational exposure to DNA-damaging agents and effect of confounding factors.
2000 Standout
Assessment of genotoxic damage in nurses occupationally exposed to antineoplastics by the analysis of chromosomal aberrations
2002
Drug Resistance in Cancer: An Overview
2014 Standout
Coumarins and Coumarin-Related Compounds in Pharmacotherapy of Cancer
2020 Standout
Evaluation of methoxsalen, tranylcypromine, and tryptamine as specific and selective CYP2A6 inhibitors in vitro.
2001
Genetic Variability inCYP2A6and the Pharmacokinetics of Nicotine
2007
Works of B. Sinués being referenced
Levels of Vancomycin in Aqueous Humor After Topical Eye Drops Administration
1993
Lack of effect of growth hormone replacement therapy on CYP1A2 and xanthine oxidase activities in growth hormone–deficient children
2006
Cytogenic Effects of Diatrizoate and Ioxaglate on Patients Undergoing Excretory Urography
1990
Micronucleus assay in biomonitoring of patients undergoing excretory urography with diatrizoate and ioxaglate
1991
Genotyping of human cytochrome P450 2A6 (CYP2A6), a nicotine C‐oxidase
1998
Characterization of a novelCYP2A7/CYP2A6 hybrid allele (CYP2A6*12) that causes reduced CYP2A6 activity
2002
Chromosome aberrations and urinary thioethers in smokers
1990
Haplotype structure and allele frequencies ofCYP2B6in Spaniards and Central Americans
2009
Sister chromatid exchanges, proliferating rate index, and micronuclei in biomonitoring of internal exposure to vinyl chloride monomer in plastic industry workers
1991
Characterisation and PCR‐based detection of a CYP2A6 gene deletion found at a high frequency in a Chinese population
1999
CYP2A6 activity in a healthy Spanish population: effect of age, sex, smoking, and oral contraceptives
2008
Five caffeine metabolite ratios to measure tobacco-induced CYP1A2 activity and their relationships with urinary mutagenicity and urine flow.
1999
[Erythrocyte glutathione and urinary thioethers in smokers].
1990
Ten percent of North Spanish individuals carry duplicated or triplicated CYP2D6 genes associated with ultrarapid metabolism of debrisoquine
1999